Press Releases

  • News
  • Articles
  • Interviews
  • Business India Sept’21 Edition: JB Chemicals is all geared up to start its next growth phase!
    20.09.2021
    Read More
  • JB Chemicals Strong Run Of Growth Continues With International Rise
    13.09.2021
    Read More
  • KKR-controlled drug maker JBCPL evaluating acquistion of select brands, mid-sized firm
    13.09.2021
    Read More
  • KKR-backed JB Chemicals scouting for acquisitions
    13.09.2021
    Read More
  • Q1 FY22 Results Sheet
    26.08.2021
    Read More
  • Disclosure of material event/information – Transcript of Earnings conference call – Q1 FY22
    19.08.2021
    Read More
  • Q2 FY21 Results Sheet
    17.08.2021
    Read More
  • Q1 FY21 Results Sheet
    17.08.2021
    Read More
  • Q1 FY 22 Earnings Conference Call Transcript
    13.08.2021
    Read More
  • Important communication with regard to TDS on dividend
    12.08.2021
    Read More
  • Presentation made to Investors – 12.08.2021
    12.08.2021
    Read More
  • Grant of Options under Employee Stock Option Scheme
    11.08.2021
    Read More
  • Board to consider and declare interim dividend for FY 2020-21
    03.08.2021
    Read More
  • Unaudited Financial Results 31.12.2020
    03.08.2021
    Read More
  • Declaration of Interim Dividend
    03.08.2021
    Read More
  • Press Release for Unaudited Financial Results – 31.12.2020
    03.08.2021
    Read More
  • Presentation made to Investors – 10.02.2021
    03.08.2021
    Read More
  • Schedule of meeting with institutional investors
    03.08.2021
    Read More
  • Registration/ Log-in details for virtual call with management on 02.03.2021
    03.08.2021
    Read More
  • Presentation made to Investors – 02.03.2021
    03.08.2021
    Read More
  • Outcome of Board meeting
    03.08.2021
    Read More
  • Institution of new Employee Stock Option Scheme
    03.08.2021
    Read More
  • Launch of new dedicated division “RENOVA” to enter Nephrology segment in India
    03.08.2021
    Read More
  • Disclosure of receipt of requests from the promoters/ promoter group members seeking re-classification of status as public
    03.08.2021
    Read More
  • Notice of Board Meeting
    03.08.2021
    Read More
  • Recommendation of final dividend
    03.08.2021
    Read More
  • Schedule of Investors/ Analysts’ call with management on 15.06.2021 and Registration/Log-in details for the same
    03.08.2021
    Read More
  • Audited Financial Results 31.03.2021
    03.08.2021
    Read More
  • Recommendation of Final Dividend for FY 2020-21
    03.08.2021
    Read More
  • Views of Board of Directors on the Reclassification Request
    03.08.2021
    Read More
  • Press Release for Audited Financial Results – 31.03.2021
    03.08.2021
    Read More
  • Newspaper cutting of extract of Consolidated Financial Results 31.03.2021
    03.08.2021
    Read More
  • Instructions
    03.08.2021
    Read More
  • Postal Ballot Form
    03.08.2021
    Read More
  • Postal Ballot Notice – 25.06.2021
    03.08.2021
    Read More
  • Newspaper advertisement for Postal Ballot
    03.08.2021
    Read More
  • Disclosure of material event/information – Newspaper Advertisement
    03.08.2021
    Read More
  • Results of Postal Ballot
    03.08.2021
    Read More
  • Disclosure of material event/information – Newspaper Advertisement
    23.07.2021
    Read More
  • Intimation of Record Date
    19.07.2021
    Read More
  • Postal Ballot Form
    19.07.2021
    Read More
  • Disclosure of material event/information – 02.07.2021
    19.07.2021
    Read More
  • Disclosure of material event/information – Change in Company Secretary & Compliance officer
    19.07.2021
    Read More
  • Notice of Annual general Meeting scheduled on September 9, 2021
    19.07.2021
    Read More
  • Disclosure of material event/information – Change in Company Secretary & Compliance officer
    14.07.2021
    Read More
  • Newspaper advertisement for Postal Ballot
    03.07.2021
    Read More
  • Disclosure of material event/information – 02.07.2021
    02.07.2021
    Read More
  • Press Release for Unaudited Financial Results – 30.06.2021
    30.06.2021
    Read More
  • Q1 FY22 Earnings Call Audio
    30.06.2021
    Read More
  • Postal Ballot Notice – 25.06.2021
    25.06.2021
    Read More
  • Earnings Conference Call on Q1 FY 21-22 – Audio recording
    20.06.2021
    Read More
  • Q4 FY21 Earnings Call Transcript
    15.06.2021
    Read More
  • Newspaper cutting of extract of Consolidated Financial Results 31.03.2021
    15.06.2021
    Read More
  • Presentation made to Investors – 14.06.2021
    14.06.2021
    Read More
  • Recommendation of Final Dividend for FY 2020-21
    14.06.2021
    Read More
  • Newspaper advertisement for Book Closure / Record Date
    15.02.2021
    Read More
  • Disclosure of material event/ information – Appointment of Non-executive Director 10.02.2021
    10.02.2021
    Read More
  • Disclosure of material event/ information – Resignation of a director 10.02.2021
    10.02.2021
    Read More
  • Intimation of Record Date
    10.02.2021
    Read More
  • Newspaper cutting of extract of Consolidated Unaudited Financial Results 31.12.2020
    31.12.2020
    Read More
  • Schedule of meeting with institutional investors – 16.12.2020
    16.12.2020
    Read More
  • Newspaper Advertisement for Postal Ballot
    25.11.2020
    Read More
  • Result of Postal Ballot
    20.11.2020
    Read More
  • Disclosure of material event/ information – Appointment of auditors 10.11.2020
    10.11.2020
    Read More
  • Disclosure of material event/ information – Resignation of auditors 10.11.2020
    10.11.2020
    Read More
  • Disclosure of material event/ information – Resignation of a director 10.11.2020
    10.11.2020
    Read More
  • Press Release for Unaudited Financial Results – 30.09.2020
    10.11.2020
    Read More
  • Letter of offer for Open Offer
    16.10.2020
    Read More
  • Disclosure of material event/ information – Appointment of auditors 10.11.2020
    11.10.2020
    Read More
  • Disclosure of material event/ information – Resignation of a director 05.10.2020
    05.10.2020
    Read More
  • Appointment of Chief Executive Officer & Whole-time Director
    05.10.2020
    Read More
  • Announcement of Appointment of Mr. Nikhil Chopra as CEO
    05.10.2020
    Read More
  • Notice of Annual general Meeting scheduled on September 30, 2020
    30.09.2020
    Read More
  • Newspaper Cutting of extract of consolidated Unaudited Financial Results 30.09.2020
    30.09.2020
    Read More
  • Result of voting on the business transacted at the Annual General Meeting held on 30-09-2020
    30.09.2020
    Read More
  • Notice of Annual General Meeting scheduled on September 24, 2020
    24.09.2020
    Read More
  • Notice of Annual General meeting to be held on 30.09.2020 published in newspaper
    09.09.2020
    Read More
  • Intimation of Record date
    08.09.2020
    Read More
  • Advertisement for dispatch of Letter of offer
    05.09.2020
    Read More
  • Notice of Board Meeting
    05.09.2020
    Read More
  • Resignation of Independent Directors
    01.09.2020
    Read More
  • Change in Board of Directors
    31.08.2020
    Read More
  • Disclosure of material event/information – Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited
    28.08.2020
    Read More
  • Disclosure of material event/information Open Offer by Tau Investment Holdings Pte. Ltd.-Extension of time for dispatch of Letter of Offer granted by SEBI
    28.08.2020
    Read More
  • Recommendation of Committee of Independent Directors (“IDC”) under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended
    27.08.2020
    Read More
  • Notice of Annual General meeting published in news paper
    18.08.2020
    Read More
  • Prior Public Notice with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM)
    14.08.2020
    Read More
  • Disclosure of material event/information – Demise of Chairman & Managing Director Shri Jyotindra B. Mody
    22.07.2020
    Read More
  • Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited
    14.07.2020
    Read More
  • Disclosure of material event/information – Public Announcement of open offer
    02.07.2020
    Read More
  • Press Release for Unaudited Financial Results – 30.06.2020
    30.06.2020
    Read More
  • Recommendation of Final Dividend for FY 2019-20
    25.06.2020
    Read More
  • Notice of Board Meeting
    11.06.2020
    Read More
  • ANDA approval by US FDA
    27.04.2020
    Read More
  • Postal Ballot Notice
    13.04.2020
    Read More
  • Disclosure of material event/information – Supreme Court judgement on orders passed by National Green Tribunal
    03.04.2020
    Read More
  • News about Ranitidine formulations in the US
    02.04.2020
    Read More
  • Annual Report of 2019-20
    20.03.2020
    Read More
  • Q4 FY20 Results Sheet
    03.03.2020
    Read More
  • Q3 FY20 Results Sheet
    03.03.2020
    Read More
  • Q1 FY20 Results Sheet
    03.03.2020
    Read More
  • Disclosure of material event/information –Institutional investors meet.
    20.02.2020
    Read More
  • Board to consider and declare interim dividend for F.Y. 2019-20
    20.02.2020
    Read More
  • Declaration of Interim Dividend
    20.02.2020
    Read More
  • Intimation of Record Date
    20.02.2020
    Read More
  • US FDA approval of New Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat
    11.02.2020
    Read More
  • Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat
    10.02.2020
    Read More
  • Acquisition of Trademarks
    04.02.2020
    Read More
  • Schedule of meeting with institutional investors 28.01.2020
    28.01.2020
    Read More
  • Earnings Call
    28.01.2020
    Read More
  • Earnings Call
    28.01.2020
    Read More
  • Presentation made to Investors – 04.02.2020
    31.12.2019
    Read More
  • J. B. Chemicals clears the confusion around Rantac® (Ranitidine)
    20.12.2019
    Read More
  • Regulatory one-time increase in price of Metronidazole Formulations
    16.12.2019
    Read More
  • Approval for re-classification of certain promoter group members to public
    28.11.2019
    Read More
  • Draft Letter of Offer for Buy-back of Equity Shares
    18.11.2019
    Read More
  • Public Announcement – Buy-back of shares
    13.11.2019
    Read More
  • Outcome of Board Meeting – Buy-back of Equity shares by the Company
    12.11.2019
    Read More
  • Intimation of Record Date for the proposed Buy-back of Equity shares by the Company
    12.11.2019
    Read More
  • Letter of Offer for Buy-back of Equity Shares
    12.11.2019
    Read More
  • Notice of Board Meeting – to consider & approve proposal for Buy-back
    06.11.2019
    Read More
  • Notice of Board Meeting
    04.10.2019
    Read More
  • News about presence of NDMA in Ranitidine
    30.09.2019
    Read More
  • Press Release for Unaudited Financial Results – 30.09.2019
    30.09.2019
    Read More
  • Disclosure of material event/information – Resignation of a director – 30.09.2019
    30.09.2019
    Read More
  • FY20 Strategy Presentation
    20.09.2019
    Read More
  • Disclosure of material event/information – September 12, 2019
    12.09.2019
    Read More
  • Disclosure of material event/information – August 30, 2019
    30.08.2019
    Read More
  • Disclosure of material event/information – August 28, 2019
    28.08.2019
    Read More
  • Disclosure of material event/information – August 27, 2019
    27.08.2019
    Read More
  • Result of voting on the business transacted at the Annual General Meeting held on 23-08-2019
    23.08.2019
    Read More
  • Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 and Code for fair disclosure of UPSI
    15.07.2019
    Read More
  • Disclosure of material event/information – May 21, 2019
    21.05.2019
    Read More
  • Recommendation of Dividend for FY 2018-19
    21.05.2019
    Read More
  • Disclosure of material event/information – May 14, 2019
    14.05.2019
    Read More
  • Disclosure of material event/information – May 13, 2019
    13.05.2019
    Read More
  • Recommendation of Dividend
    08.05.2019
    Read More
  • Notice of Board Meeting April/05/2019
    19.04.2019
    Read More
  • Press Release for Audited Financial Results – 31.03.2019
    31.03.2019
    Read More
  • Q4 FY19 Results Sheet
    30.03.2019
    Read More
  • Notice of Board Meeting Jan/10/2019
    10.02.2019
    Read More
  • Press Release for Unaudited Financial Results – 31.12.2017
    09.02.2019
    Read More
  • Press Release for Unaudited Financial Results – 31.12.2018
    31.12.2018
    Read More
  • Q3 FY19 Results Sheet
    31.12.2018
    Read More
  • ANDA approval by US FDA
    05.11.2018
    Read More
  • Update on disclosure of material event/ information – November 5, 2018
    05.11.2018
    Read More
  • Press Release for Unaudited Financial Results – 30.09.2018
    02.11.2018
    Read More
  • Tender Form (demat shares)
    10.10.2018
    Read More
  • Tender Form (physical shares)
    10.10.2018
    Read More
  • Unaudited Financial Results 30.09.2018
    30.09.2018
    Read More
  • Q2 FY19 Results Sheet
    30.09.2018
    Read More
  • Post buyback Public Announcement
    04.09.2018
    Read More
  • Notice of Annual General Meeting to be held on September 4, 2018
    04.09.2018
    Read More
  • Result of voting on the business transacted at the Annual General Meeting held on 04-09-2018
    04.09.2018
    Read More
  • Outcome of Board Meeting – Buy-back of Equity Shares by the Company
    31.08.2018
    Read More
  • Intimation of Record Date for the proposed Buy-back of equity shares by the Company
    31.08.2018
    Read More
  • Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat
    27.08.2018
    Read More
  • Notice of Board Meeting – to consider & approve proposal for Buy-back
    23.08.2018
    Read More
  • Public Announcement for Buy-back of Equity shares
    20.08.2018
    Read More
  • Share transfer Form (physical shares)
    20.08.2018
    Read More
  • Notice of Annual General Meeting published in Newspapers
    06.08.2018
    Read More
  • Change in dividend payment date
    02.08.2018
    Read More
  • Notice of Board Meeting
    25.07.2018
    Read More
  • Update on disclosure of material event/ information
    24.07.2018
    Read More
  • Press Release for Unaudited Financial Results – 30.06.2018
    30.06.2018
    Read More
  • Q1 FY19 Results Sheet
    30.06.2018
    Read More
  • Audited Financial Results 31.03.2018
    28.05.2018
    Read More
  • Press Release for Audited Financial Results – 31.03.2018
    25.05.2018
    Read More
  • Successful US FDA inspection of API Manufacturing facility at Panoli, Gujarat
    14.05.2018
    Read More
  • Board Meeting Intimation
    27.04.2018
    Read More
  • Update on material event/ information – April 24, 2018
    24.04.2018
    Read More
  • Disclosure of material event / information
    19.04.2018
    Read More
  • Disclosure of material event/ information – April 19,2018
    19.04.2018
    Read More
  • Draft Letter of Offer for Buy-back of Equity Shares
    31.03.2018
    Read More
  • Letter of Offer
    31.03.2018
    Read More
  • Meeting with institutional investors
    23.02.2018
    Read More
  • Schedule of meeting with institutional investors
    21.02.2018
    Read More
  • Unadited Financial Results 31.12.2017
    31.12.2017
    Read More
  • Notice of Board Meeting
    27.10.2017
    Read More
  • Q2 FY18 Results Sheet
    30.09.2017
    Read More
  • Press Release for Unaudited Financial Results – 30.09.2017
    30.09.2017
    Read More
  • Notice of Annual General Meeting to be held on September 19, 2017
    19.09.2017
    Read More
  • Result of voting on the business transacted at the Annual General Meeting held on 19-09-2017
    19.09.2017
    Read More
  • Change in dividend payment date
    22.08.2017
    Read More
  • Public Announcement for Buy-back of Equity shares
    21.08.2017
    Read More
  • Share transfer Form (physical shares)
    21.08.2017
    Read More
  • Notice of Board Meeting
    27.07.2017
    Read More
  • Tender Form (physical shares)
    03.07.2017
    Read More
  • Tender Form (demat shares)
    03.07.2017
    Read More
  • Press Release for Unaudited Financial Results – 30.06.2017
    30.06.2017
    Read More
  • Undited Financial Results 30.06.2017
    03.06.2017
    Read More
  • Draft letter of offer for Buy-back of Equity shares
    02.06.2017
    Read More
  • Post Buy-back Public Advertisement
    02.06.2017
    Read More
  • Post Buy-back Public Advertisement
    24.05.2017
    Read More
  • Recommendation of Dividend for the F.Y.2016-17
    23.05.2017
    Read More
  • Intimation of Record Date for the proposed Buy-back of shares
    23.05.2017
    Read More
  • Buy-back of Equity Shares
    23.05.2017
    Read More
  • Board of Directors to consider the proposal for Buy-back of equity shares
    17.05.2017
    Read More
  • Notice of Board Meeting
    04.05.2017
    Read More
  • Recommendation of Dividend
    04.05.2017
    Read More
  • Audited Financial Results 31.03.2017
    31.03.2017
    Read More
  • Press Release for Audited Financial Results – 31.03.2017
    31.03.2017
    Read More
  • Press Release for Audited Financial Results – 31.03.2017
    31.03.2017
    Read More
  • Unaudited Financial Results 31.12.2016
    10.02.2017
    Read More
  • Notice of Board Meeting
    25.01.2017
    Read More
  • Resignation of a director – Dr. Niranjan Maniar
    23.11.2016
    Read More
  • Notice of Board Meeting
    04.10.2016
    Read More
  • Q2 FY17 Results Sheet
    30.09.2016
    Read More
  • Press Release for Unaudited Financial Results – 30.09.2016
    30.09.2016
    Read More
  • Resignation of a director – Mr. Jashvantrai Joshi
    29.09.2016
    Read More
  • Notice of Annual General Meeting to be held on August 23, 2016
    23.08.2016
    Read More
  • Result of voting on the business transacted at the Annual General Meeting held on 23-08-2016
    23.08.2016
    Read More
  • Notice of Board Meeting
    22.07.2016
    Read More
  • Update on material event/ information – 18 July 2016
    18.07.2016
    Read More
  • Q1 FY17 Results Sheet
    30.06.2016
    Read More
  • Press Release for Unaudited Financial Results – 30.06.2016
    30.06.2016
    Read More
  • Recommendation of Final Dividend
    20.05.2016
    Read More
  • Update on material event/ information – 19 May 2016
    19.05.2016
    Read More
  • Notice of Board Meeting
    20.04.2016
    Read More
  • Update on material event/ information – 31 March 2016
    31.03.2016
    Read More
  • Press Release for Audited Financial Results – 31.03.2016
    31.03.2016
    Read More
  • Update on material event/ information – 29 March 2016
    29.03.2016
    Read More
  • Resignation of a director – Mr. Mahesh K. Shroff
    11.03.2016
    Read More
  • Update on material event/ information – 11 March 2016
    11.03.2016
    Read More
  • Declaration of Interim Dividend
    11.03.2016
    Read More
  • Update on material event/ information – 4 March 2016
    04.03.2016
    Read More
  • Update on material event/ information – 9 February 2016
    09.02.2016
    Read More
  • Notice of Board Meeting
    03.02.2016
    Read More
  • Appointment of Independent director- Mr. Shaukat Merchant
    03.02.2016
    Read More
  • Disclosure of material event / information
    13.01.2016
    Read More
  • Unaudited Financial Results 31.12.2015
    31.12.2015
    Read More
  • Press Release for Unaudited Financial Results – 31.12.2015
    31.12.2015
    Read More
  • Information under clause 36 of the Listing Agreement
    05.11.2015
    Read More
  • Unaudited financial results 30.09.2015
    30.09.2015
    Read More
  • Press Release for Unaudited Financial Results – 30.09.2015
    09.09.2015
    Read More
  • Notice of Annual General Meeting to be held on August 19, 2015
    19.08.2015
    Read More
  • Results of voting on the business transacted at the Annual General Meeting held on 19.08.2015
    18.08.2015
    Read More
  • Recommendation of Special dividend and regular dividend
    13.08.2015
    Read More
  • Intimation of change in dividend payment date
    09.07.2015
    Read More
  • Intimation of Book Closure
    09.07.2015
    Read More
  • Unaudited Financial Results 30.06.2015
    30.06.2015
    Read More
  • Press Release for Unaudited Financial Results – 30.06.2015
    30.06.2015
    Read More
  • Notice of Board Meeting
    30.06.2015
    Read More
  • Audited Financial Results 2014 -15
    20.05.2015
    Read More
  • Press Release for Audited Financial Results – 2014-15
    20.05.2015
    Read More
  • Notice of Board Meeting
    05.05.2015
    Read More
  • Business India Sept’21 Edition: JB Chemicals is all geared up to start its next growth phase!
    20.09.2021
    Read More
  • JB Chemicals & Pharmaceuticals seeks to expand market for prescription lozenges with new launches
    13.09.2021
    Read More
  • KKR-owned JBCPL to aggressively scale up, acquire local drug brands
    13.09.2021
    Read More
  • KKR-backed JB Chemicals scouts for acquisitions, plans to revamp business
    13.09.2021
    Read More
  • Leader Speaks – Interview with Mr.Nirav Mody on October India Infoline
    12.08.2021
    Read More
  • J. B. Chemicals in the Forbes Global list of best under $1 billion in Asia Pacific
    11.01.2004
    Read More
  • My role is to act like a catalyst
    13.09.2021
    Read More
  • How will Pharma 2021 unfold?
    13.09.2021
    Read More
  • Healthcare has started getting the type of attention it deserves
    13.09.2021
    Read More
  • My role is to act like a catalyst
    13.09.2021
    Read More